About a third of all US healthcare spending — roughly $1.4 trillion per year — is obesity-related, comparable in scale to the entire Defense Department budget.
Snapshot · The Prof G Pod with Scott Galloway
About a third of all US healthcare spending — roughly $1.4 trillion per year — is obesity-related, comparable in scale to the entire Defense Department budget.
Where this was said
At 9:09 · chapter starts 7:50
Most chronic disease drugs, Ricks explains, work for some people and not others — and patients typically feel worse taking them. GLP-1s break this pattern on both counts: nearly universal efficacy and a subjective experience patients actually welcome. That's unusual. Add the fact that obesity connects causally to more than 200 chronic diseases — from diabetes and cardiovascular disease to inflammation and cancer — and you have what Ricks calls a 'nodal' health condition. Fix obesity at scale and you potentially pull down a cascade of downstream costs and suffering. Galloway layers in the macro: US healthcare costs $13,500 per person versus Japan's $5,500, and the countries' obesity rates differ by roughly 36 percentage points. His thesis: you cannot address the US fiscal deficit without addressing healthcare, and you cannot address healthcare without addressing obesity. Ricks largely agrees.
The US spends $13,500 per person on healthcare versus Japan's $5,500, with the US having a 40% obesity rate compared to Japan's 4%.
About a third of all US healthcare spending is obesity-related — roughly $1.4 trillion annually. That's comparable to the entire US Defense Department budget, and it's almost entirely driven by downstream chronic diseases like diabetes, cardiovascular disease, and joint failure.
Approximately two-thirds of Eli Lilly's total sales come from GLP-1-related products, making it essentially a pure-play index fund on the technology.
GLP-1 drugs don't just help people lose weight — they reduce inflammation, cardiovascular disease risk, and are linked to lower cancer rates. Obesity is a nodal condition upstream of over 200 chronic diseases, making these drugs uniquely high-leverage for public health.
Spencer Greenberg and Jeremy Stevenson analyzed almost 500 self-improvement techniques and found they all reduce to just 12 underlying psychological drivers.
Cold exposure has good short-term alertness benefits but the evidence base for long-term health benefits is much weaker than popularly believed.
In a randomized study of 20 habit-formation techniques run on hundreds of people, almost none of the techniques produced statistically meaningful results.
People given a tiny-habit fallback option (e.g. 10 squats instead of gym) were actually MORE successful at completing the full habit, not less.
The most effective habit-formation technique was 'habit reflection' — recalling a past successful habit, writing down what helped, then applying those lessons to a new habit.
A study found that simply scheduling enjoyable activities was as effective as standard cognitive behavioral therapy for depression, leading to its own therapy called behavioral activation.
The 'worry time' technique — deferring all worries to a designated time of day — helps people realize they have more control over worry than they thought and reveals it is less useful than it feels.
A study found that participants told to try to stay awake while in bed fell asleep faster than participants told to try to sleep — illustrating the paradox of direct effort.
Spencer Greenberg reduced his severe social anxiety dramatically in roughly 6 months through a structured exposure therapy hierarchy, culminating in asking strangers for hugs.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.